AstraZeneca India receives CDSCO approval for Durvalumab in combination with FLOT chemotherapy EP News Bureau Feb 3, 2026 AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announces the Central Drugs Standard Control…
